media – Page 584 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

New study links migraines to increased risk of cardiovascular problems

© Provided by AFPRelaxNews Migraine sufferers could be at an increased risk of certain heart problems according to new research.New international research has found that migraine sufferers may also have an increased risk of cardiovascular problems including heart attacks, stroke, blood clots, and an irregular heart rate.
- Source: msn
- 653
- February 8, 2018
cardiovascular migraine Researches
NHS tells doctors to order stronger vaccine for next winter

England is not alone in being particularly hard hit this flu season, with Australia suffering its worst flu season in two decades and the US now grappling with a severe flu outbreak.
- Source: pharmafile
- 627
- February 8, 2018
flu outbreak NHS polices QIV
FDA Calls Bay Area Zogenix’s Dravet Syndrome Drug a Breakthrough

Zogenix Announces Receipt of FDA Breakthrough Therapy Designation for ZX008 in Dravet Syndrome.
- Source: Biospace
- 511
- February 8, 2018
Dravet syndrome FDA New Approvals ZX008
AMAG Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application (sNDA) for Feraheme® (ferumoxytol injection)

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the U.S. Food and Drug Administration (FDA) has approved its application to broaden the existing label for Feraheme® (ferumoxytol injection) beyond the current chronic kidney disease (CKD) indication to include all eligible adult Iron Deficiency Anemia (IDA) patients who have intolerance to oral iron or have had unsatisfactory response to oral iron.
- Source: Amagpharma
- 707
- February 8, 2018
chronic kidney disease FDA Feraheme New Approvals
De Rothschild raises €345M Europe-skewed life science fund

Edmond De Rothschild Investment Partners has raised €345 million ($430 million) for its latest fund. The haul makes BioDiscovery 5 the largest fund dedicated to biotechs and medical devices in Europe and tees up Edmond De Rothschild to invest in 15 to 17 companies.
- Source: FierceBiotech
- 583
- February 8, 2018
biotech Company Insight medical device
Has Health IT Adoption Improved Patient Outcomes?

It had been a few years since the last systematic literature review of the effect health information technology (HIT) has on patient outcomes, and much has changed since. The Health Information Technology for Economic and Clinical Health (HITECH) Act of 2009 encouraged widespread electronic health record (EHR) adoption, vaulting them to near-ubiquity.
- Source: HCANews
- 1,161
- February 8, 2018
health IT Market Views Researches
Amazon Wants to Disrupt Health Care in America. In China, Tech Giants Already Have

Amazon and two other American titans are trying to shake up health care by experimenting with their own employees’ coverage. By Chinese standards, they’re behind the curve.
- Source: New York Times
- 579
- February 8, 2018
digital health health IT Market Views
Pfizer vs J&J– Researchers are duking it out for the championship title in nonmetastatic prostate cancer

Pfizer $PFE and J&J $JNJ have come down to the wire with pivotal data on nonmetastatic prostate cancer. And there are billions of dollars in revenue on the line here.
- Source: Endpts
- 467
- February 7, 2018
Market Views prostate cancer
Heart Study app could be Apple’s first FDA-cleared product

The Apple Heart Study — which began enrollment at the end of November — has now begun data collection, with participants receiving prompts over the weekend to sign informed consent documents and initiate data collection. That document also reveals some new details about how Apple plans to use data collected during the study.
- Source: MobiHealthNews
- 1,045
- February 7, 2018
App Apple Company Insight FDA mHealth
Medial EarlySign’s AI scans medical records for diabetes warning signs

A machine learning technology developed to spot dangerous medical conditions before they worsen has shown its value in a trial.
- Source: PharmaPhorum
- 594
- February 7, 2018
AI diabetes NHS Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.